HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOGEN-B

46.900

+1.5003.30%

Volume:866.87K

Turnover:39.91M

Market Cap:21.42B

PE:-102.93

High:46.920

Open:45.400

Low:44.740

Close:45.400

52wk High:74.000

52wk Low:40.080

Shares:456.82M

HK Float Shares:420.29M

Volume Ratio:1.57

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.456

ROE:-23.27%

ROA:-11.61%

PB:28.67

PE(LYR):-102.93

PS:346.77

Loading ...

Overview Company News Filings

BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 Million

INNOGEN-B (02591) Subscribes to Structured Deposit Products

Guangzhou Innogen Pharmaceutical Group Co., Ltd. Announces Expansion in Pharmaceutical Research and Development

Guangzhou Innogen Pharmaceutical - on 18 August, Unit Subscribes for Cmb Structured Deposit for RMB30 Mln

THOMSON REUTERS

Innogen Pharmaceutical Widens H1 Loss; Shares Slip 6%

MT Newswires Live

INNOGEN-B (02591) Reports Interim Results with R&D Expenses of RMB 99.082 Million, Up 90.89% Year-on-Year

Guangzhou Innogen Reports RMB 56.4 Million Revenue for H1 2025 with Gross Profit of RMB 50.5 Million

INNOGEN-B (02591) Completes First Patient Dosing in Phase II Clinical Trial of Isupaglutide Alpha for Obesity and Overweight Treatment in Australia

Integrated R&D-Manufacturing-Sales Model Strengthens Competitive Edge: SUNSHINE PHARMA (06887) Advances Over 100 Pipeline Drugs with Notable BD Progress

Hong Kong IPO Weekly Report: 18A Biotech IPO Wave Returns! AB&B BIO-TECH-B and INNOGEN-B Surge on Debut

"Chinese Semaglutide" Company Just Completed Its IPO

Innogen Pharma Soars 285% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | Innogen-B Skyrockets 288.65% on Hong Kong Debut, Riding GLP-1 Drug Market Wave

Innogen Pharma Nets HK$635 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live

INNOGEN-B (02591) Surges 270% in Grey Market Trading as GLP-1 Sector Gains Spotlight, PEGBIO CO-B (02565) Presents Value Investment Opportunity

New Stock Dark Pool | INNOGEN-B (02591) Surges 265.10% in Early Dark Pool Trading, Earning HK$9,904 Per Lot

HK Movers | Innogen Pharmaceutical Soars 275% in Grey Market Trading

Tiger Newspress

BRIEF-Guangzhou Innogen Pharmaceutical Group Announces Global Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02591/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":46.9,"timestamp":1757405291257,"preClose":45.4,"halted":0,"volume":866870,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.45564999690838864,"marketStatus":"Closed","change":1.5,"latestTime":"09-09 16:08:11","open":45.4,"high":46.92,"low":44.74,"amount":39909166,"amplitude":0.048018,"askPrice":46.9,"askSize":200,"bidPrice":46.8,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-0.45564999690838864,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757467800000},"marketStatusCode":5,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":45.4,"openAndCloseTimeList":[[1757381400000,1757390400000],[1757394000000,1757404800000]],"volumeRatio":1.565137,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.45565,"volumeRatio":1.565137,"shares":456819349,"dividePrice":0,"high":46.92,"amplitude":0.048018,"preClose":45.4,"low":44.74,"week52Low":40.08,"pbRate":"28.67","psRate":"346.77","week52High":74,"institutionHeld":0,"latestPrice":46.9,"committee":0.8,"eps":-0.45564999690838864,"divideRate":0,"volume":866870,"delay":0,"ttmEps":-0.45564999690838864,"open":45.4,"prevYearClose":18.68,"prevWeekClose":41.46,"prevMonthClose":44.48,"prevQuarterClose":18.68,"fiveDayClose":41.6,"twentyDayClose":18.68,"sixtyDayClose":18.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2025-09-05","current":-78.151342,"percent":0.933333,"low":-137.156472,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"high":-76.944953,"avg":-111.327861,"sd":19.174818,"marketCap":18939730209},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209}],"updateTime":1757373935928},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564843137","title":"BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2564843137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564843137?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:57","pubTimestamp":1756738651,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical's Unit On 18 August Subscribes For CMB Structured Deposit For Rmb30 MillionSept 1  - Guangzhou Innogen Pharmaceutical Group Co Ltd 2591.HK:ON 18 AUGUST, UNIT SUBSCRIBES FOR CMB STRUCTURED DEPOSIT FOR RMB30 MILLIONFurther company coverage: 2591.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UO0BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1105178687","title":"INNOGEN-B (02591) Subscribes to Structured Deposit Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1105178687","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105178687?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:36","pubTimestamp":1756737374,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on August 18, 2025, Innogen Technology (a directly wholly-owned subsidiary of the company) subscribed to a China Merchants Bank structured deposit product for a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2564848079","title":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. Announces Expansion in Pharmaceutical Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2564848079","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564848079?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:33","pubTimestamp":1756737200,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd., a prominent holding company in the pharmaceutical industry, is expanding its operations to enhance its research, development, and commercialization capabilities. The group, which includes subsidiaries such as Haikou Innogen Pharmaceutical Technology Co., Ltd. and Innogen Technology, focuses on pharmaceutical production and sales as well as advanced research and development. This expansion aligns with the company's strategic goals to strengthen its market presence and drive innovation in the pharmaceutical sector. The move follows the recent listing of its H Shares on the Main Board of the Stock Exchange, marking a significant milestone in its growth trajectory.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nNDL1BS4Bj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2564075848","title":"Guangzhou Innogen Pharmaceutical - on 18 August, Unit Subscribes for Cmb Structured Deposit for RMB30 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2564075848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564075848?lang=en_us&edition=fundamental","pubTime":"2025-09-01 22:33","pubTimestamp":1756737196,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UO0BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591"],"gpt_icon":0},{"id":"2564892561","title":"Innogen Pharmaceutical Widens H1 Loss; Shares Slip 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564892561","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564892561?lang=en_us&edition=fundamental","pubTime":"2025-09-01 15:48","pubTimestamp":1756712929,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical  widened its attributable loss in the first half of 2025 to 122.5 million yuan from 75.3 million yuan in the year-ago period, an Aug. 29 filing with the Hong Kong bourse said.Shares of the pharmaceutical company were down 6% in Monday afternoon trading.Loss per share rose to 0.29 yuan in the six months from 0.18 yuan in the corresponding period of the last year.Revenue stood at 56.4 million yuan in the period, mainly from sales of Efsubaglutide Alfa in China.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02591"],"gpt_icon":0},{"id":"1103675420","title":"INNOGEN-B (02591) Reports Interim Results with R&D Expenses of RMB 99.082 Million, Up 90.89% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1103675420","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103675420?lang=en_us&edition=fundamental","pubTime":"2025-08-29 22:38","pubTimestamp":1756478306,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced its interim financial results for the six months ended June 30, 2025, reporting revenue of RMB 56.446 million (compared to no revenue in the same period last year), gross...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2563021329","title":"Guangzhou Innogen Reports RMB 56.4 Million Revenue for H1 2025 with Gross Profit of RMB 50.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563021329","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563021329?lang=en_us&edition=fundamental","pubTime":"2025-08-29 21:54","pubTimestamp":1756475696,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. has announced its unaudited consolidated interim results for the six months ended June 30, 2025. The company reported a revenue of RMB 56.446 million, all derived from the sales of pharmaceutical products in Mainland China. The cost of sales stood at RMB 5.956 million, resulting in a gross profit of RMB 50.490 million. No comparative figures for the previous period were provided for the revenue and gross profit. The company's operations remain focused on the sales of pharmaceutical products within the People's Republic of China, with no geographical diversification in its revenue sources.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Innogen Pharmaceutical Group Co. Ltd. publi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL4p8kvS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1199111904","title":"INNOGEN-B (02591) Completes First Patient Dosing in Phase II Clinical Trial of Isupaglutide Alpha for Obesity and Overweight Treatment in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1199111904","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199111904?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:54","pubTimestamp":1756212859,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that on August 25, 2025, the company has completed the first patient dosing in its Phase II clinical trial of Isupaglutide Alpha for the treatment of obesity and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1168975132","title":"Integrated R&D-Manufacturing-Sales Model Strengthens Competitive Edge: SUNSHINE PHARMA (06887) Advances Over 100 Pipeline Drugs with Notable BD Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1168975132","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168975132?lang=en_us&edition=fundamental","pubTime":"2025-08-18 08:56","pubTimestamp":1755478609,"startTime":"0","endTime":"0","summary":"Benefiting from intensive policy dividend releases, accelerated overseas expansion trends of innovative drugs, and sustained capital investment, the innovative pharmaceutical sector has emerged as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887","BK1191","02591"],"gpt_icon":1},{"id":"1128488469","title":"Hong Kong IPO Weekly Report: 18A Biotech IPO Wave Returns! AB&B BIO-TECH-B and INNOGEN-B Surge on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1128488469","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128488469?lang=en_us&edition=fundamental","pubTime":"2025-08-17 17:41","pubTimestamp":1755423679,"startTime":"0","endTime":"0","summary":"Since the beginning of 2025, Hong Kong's stock market has seen 53 new IPOs (plus 1 De-SPAC and 1 introduction listing), raising a total of approximately HK$130.22 billion. In the most recent week...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07226","YANG","02627","HSCEI","02591","HSTECH","BK4614"],"gpt_icon":0},{"id":"1140456337","title":"\"Chinese Semaglutide\" Company Just Completed Its IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1140456337","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140456337?lang=en_us&edition=fundamental","pubTime":"2025-08-15 12:45","pubTimestamp":1755233154,"startTime":"0","endTime":"0","summary":"At 65, scientist Wang Qinghua left his tenured position at the University of Toronto to return to a Chinese laboratory. This was in 2014, when global diabetes patients had exceeded 400 million, with...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":1},{"id":"2559995109","title":"Innogen Pharma Soars 285% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2559995109","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559995109?lang=en_us&edition=fundamental","pubTime":"2025-08-15 09:44","pubTimestamp":1755222259,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical (HKG:2591) made a stellar trading debut in Hong Kong on Friday morning as its shares opened 285% above the IPO price.The pharmaceutical company opened at HK$72.00 per share, compared with the IPO price of HK$18.68.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90acf1b4d0502abc6d715b844e35e4c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02591"],"gpt_icon":0},{"id":"1158435615","title":"Stock Track | Innogen-B Skyrockets 288.65% on Hong Kong Debut, Riding GLP-1 Drug Market Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=1158435615","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158435615?lang=en_us&edition=fundamental","pubTime":"2025-08-15 09:33","pubTimestamp":1755221609,"startTime":"0","endTime":"0","summary":"Shares of Guangzhou Innogen Pharmaceutical Group (HKG:2591) soared an astounding 288.65% as they began trading on the Hong Kong Stock Exchange on Friday. The dramatic surge reflects intense investor...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90acf1b4d0502abc6d715b844e35e4c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02591"],"gpt_icon":1},{"id":"2559671259","title":"Innogen Pharma Nets HK$635 Million from Hong Kong IPO Ahead of Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2559671259","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559671259?lang=en_us&edition=fundamental","pubTime":"2025-08-15 06:07","pubTimestamp":1755209228,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group  raised HK$634.7 million in net proceeds from its initial public offering in Hong Kong, according to a Thursday after-market Hong Kong bourse filing.The pharmaceutical firm priced its 36,556,400 H-shares at HK$18.68 apiece.The Hong Kong public offer was 5,341.66 times oversubscribed, with the final allocation of 3,655,800 shares, or about 10% of the total offering, unchanged from the initial allotment.The international offering was 10.67 times subscribed, with the final number of shares offered remaining at 32,900,600.Cornerstone investors June Star Global, Ginkgo Capital Global Fund - SPC XtalPi AI Fund SP, Marketingforce Management, Deng Haifeng, and Li Huifeng were allotted a combined 4,201,000 shares, or about 11.49% of the global offering.Guangzhou Innogen Pharma is set to debut on the Hong Kong bourse on Friday, Aug. 15.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02591"],"gpt_icon":1},{"id":"1146389586","title":"INNOGEN-B (02591) Surges 270% in Grey Market Trading as GLP-1 Sector Gains Spotlight, PEGBIO CO-B (02565) Presents Value Investment Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1146389586","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146389586?lang=en_us&edition=fundamental","pubTime":"2025-08-14 23:26","pubTimestamp":1755185206,"startTime":"0","endTime":"0","summary":"The global glucagon-like peptide-1 receptor agonist (GLP-1) drug market has experienced continuous expansion in recent years. In 2024, GLP-1 medications dominated global pharmaceutical sales rankings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90acf1b4d0502abc6d715b844e35e4c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565","BK4144","GLP","02591","BK1161","161726","399441","BK4590"],"gpt_icon":1},{"id":"1155748424","title":"New Stock Dark Pool | INNOGEN-B (02591) Surges 265.10% in Early Dark Pool Trading, Earning HK$9,904 Per Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1155748424","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155748424?lang=en_us&edition=fundamental","pubTime":"2025-08-14 16:24","pubTimestamp":1755159859,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) is scheduled to list on the Hong Kong Stock Exchange on Friday, August 15th. As of press time, dark pool trading shows the stock quoted at HK$68.2, representing a 265.10% increase...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90acf1b4d0502abc6d715b844e35e4c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"1145569564","title":"HK Movers | Innogen Pharmaceutical Soars 275% in Grey Market Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1145569564","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145569564?lang=en_us&edition=fundamental","pubTime":"2025-08-14 16:19","pubTimestamp":1755159544,"startTime":"0","endTime":"0","summary":"$Innogen Pharmaceutical(02591)$ Soars 275% in Hong Kong's Grey Market Trading","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90acf1b4d0502abc6d715b844e35e4c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2557458169","title":"BRIEF-Guangzhou Innogen Pharmaceutical Group Announces Global Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2557458169","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557458169?lang=en_us&edition=fundamental","pubTime":"2025-08-07 09:36","pubTimestamp":1754530581,"startTime":"0","endTime":"0","summary":"BRIEF-Guangzhou Innogen Pharmaceutical Group Announces Global OfferingAug 7  - Guangzhou Innogen Pharmaceutical Group:ANNOUNCES GLOBAL OFFERING OF 36.6 MILLION H SHARESOFFER PRICE UNDER GLOBAL OFFERING HK$18.68 PER H SHARENUMBER OF HONG KONG OFFER SHARES UNDER GLOBAL OFFERING 3.7 MILLION H SHARES ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nFWN3TY2BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}